Picture of Eckert & Ziegler SE logo

EUZ — Eckert & Ziegler SE News Story

0.000.00%
de flag iconLast trade - 00:00
HealthcareAdventurousMid CapFalling Star

Brief: Eckert & Ziegler And Pharmalogic Sign Reservation Agreement

Oct 10 (Reuters) - ECKERT & ZIEGLER STRAHLEN UND
MEDIZINTECHNIK AG  EUZG.DE :
    * ECKERT & ZIEGLER AND PHARMALOGIC SIGN RESERVATION
AGREEMENT FOR
SUPPLY OF THERAPEUTIC RADIOISOTOPE ACTINIUM-225
    * UNDER TERMS OF AGREEMENT, PHARMALOGIC WILL HAVE ACCESS TO
ECKERT
& ZIEGLER'S HIGH-PURITY, NON-CARRIER-ADDED ACTINIUM-225 FOR
LABELING OF RADIOPHARMACEUTICALS FOR RESEARCH AND DEVELOPMENT
WORK AND COMMERCIAL USE
    * ECKERT & ZIEGLER WILL ESTABLISH GMP-COMPLIANT PRODUCTION
OF
LARGER QUANTITIES OF AC-225 IN 2024
    * SUBSEQUENTLY, SUBMISSION OF A DRUG MASTER FILE TO UNITED
STATES
FOOD & DRUG ADMINISTRATION IS PLANNED

Source text for Eikon:  ID:nPnbwd96Ra 
Further company coverage:  EUZG.DE 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Eckert & Ziegler SE

See all news